ArticlePersonality neuroscience2026
Comparison of neuro-metabolites in borderline and antisocial personality disorders: A study based on proton magnetic resonance spectroscopy.
Article in Personality neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to investigate the neurochemical differences between borderline personality disorder (BPD) and antisocial personality disorder (ASPD) using proton magnetic resonance spectroscopy (¹H-MRS) in order to explore these disorders at a neurobiological level. In this cross-sectional study, 60 individuals with BPD and 60 individuals with ASPD participated. ¹H-MRS was performed using a Discovery MR 750 Magnetic Resonance Imaging (MRI) scanner with a 3.0 Tesla field strength to measure the levels of the metabolites GABA/Cr, N-acetylaspartate (NAA)/Cr, and glutamate (Glu)/Cr in the left anterior cingulate cortex (ACC) and the left orbitofrontal cortex (OFC) of the brain. The findings indicated that concentrations of GABA/Cr and Glu/Cr in the OFC were significantly higher in BPD patients compared to those with ASPD. In the ACC, GABA/Cr levels were elevated and NAA/Cr levels were reduced in the BPD group relative to the ASPD group. No significant differences were observed in Glu/Cr concentrations in the ACC or in NAA/Cr concentrations in the OFC. This study demonstrated significant neurochemical differences between BPD and ASPD in the ACC and OFC regions. These findings may enhance our understanding of the underlying neural mechanisms of these disorders and support the development of more targeted and effective therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.